Urography in Myelomatosis

Protein analyses in myelomatosis.

The criteria for the admission of patients to the Medical Research Council's (MRC) myeloma trials are the finding of abnormal plasma cells in bone marrow films or sections and in addition either of characteristic skeletal lesions demonstrated radiologically or of characteristic protein changes in the serum or urine. Ninety per cent of the patients in the first myeloma trial satisfied all three ...

Thromboembolic complications in myelomatosis.

claims for sick benefit reached a weekly figure of approximately 450% above the seasonal average. Strains of the Hong Kong variant of influenza virus A2 were isolated in the area. Returns from councils of absence owing to illness, believed to be influenza, during December and January were as follows. Unvaccinated 164 Off sick 41 Vaccinated once only 27 Off sick 7 Vaccinated twice 85 Off sick ni...

Antibody formation in myelomatosis.

Thromboembolic complications in myelomatosis.

Fourteen cases of myelomatosis associated with major thromboembolic complications are reported. Six patients died of pulmonary embolism, seven had deep-vein thrombosis as a presenting symptom, and three had evidence of amyloidosis. A preliminary estimate of the incidence of thromboembolism based on 376 patients admitted so far to the Medical Research Council's myelomatosis trial is about 3%, wh...

Plasma Cell Myelomatosis